View, browse and sort the list of CPhI North America Conference sessions and show floor programming by pass type, track, and format. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

Accepting the Challenge – Building a Skilled Bioprocessing Workforce - a bioLIVE Breakfast Briefing


Mary Lynne Bercik (PMP, PMI-RMP, CPSM, Founder and CEO, GenZinnovation, LLC)

Dr. Ronald G. Kander, Ph.D. (Dean, Kanbar College of Design, Engineering & Commerce Associate Provost for Applied Research, Jefferson (Philadelphia University + Thomas Jefferson University))

Location: 108A

Date: Wednesday, April 25

Time: 8:00am - 8:45am

Pass Type: Conference Pass, VIP Attendee - Get your pass now!

Track: Bio-Processing Symposium

Vault Recording: TBD

Over the last two decades, the development of immuno-oncology and next-generation cell-based therapeutics has truly revolutionized the Biologics Industry. In parallel with these advancements, a growing number of companies have also focused on rare diseases and biosimilars drug development, thereby further taxing an already constrained manufacturing Supply Chain. Given the clear shortage of skilled labor and manufacturing resources, we submit that industry can no longer afford to manage these constraints independently, and therefore must actively partner with a globally recognized Institution such as NIBRT (National Institute for Bioprocessing Research and Training) to provide world class training for professionals and students who are pursuing a career in the Biologics Manufacturing Industry. Furthermore, the inherent complexities of Biologics manufacturing mandates training programs that will support risk reduction, improve quality and efficiencies, and create innovative solutions throughout the Supply Chain. Over the past three years, highlighted in every industry forum, the feedback we have received has noted a lack a skilled workforce as our number one risk factor. The discovery of life-changing drugs is no longer our sole challenge - equally important is preserving and growing the skilled talent pool that enables the manufacturing of such innovative medicines.

Please join us to talk about how we are reducing this risk in North America with the newly created NIBRT and Jefferson Institute for Bioprocessing Partnership. Dr. Ron Kander, Dean, Kanbar College of Design, Engineering and Commerce and Associate Provost for Applied Research, Jefferson University will talk about the future of the Institute and how you and your company can become involved.